AJ302
Chemotherapy‑induced peripheral neuropathy (CIPN)
PreclinicalActive
Key Facts
Indication
Chemotherapy‑induced peripheral neuropathy (CIPN)
Phase
Preclinical
Status
Active
Company
About AnnJi Pharmaceutical
Taiwan biotech developing first‑in‑class small‑molecule therapies for neurology, immunology and fibrosis.
View full company profile